
|

| |
Track the *RXCRD Index |
 |
|
 | Cardiology Stocks (*RXCRD) |
| |
Cardiology Ideas |
|
|
|
Cardiology Performance |
|
|
|
Cardiology Community |
|
| |
|
Index Description: These medical firms have significant exposure to treatments for cardiological ailments
|
|
|
|
|
Today:
1-month:
All-time:
|
+0.3%
+6.6%
+61.6%
|
vs S&P 500:
vs S&P 500:
vs S&P 500:
|
+0.2%
+0.8%
+63.6%
|
Avg. Market Cap:
Avg. P/E Ratio:
Avg. Div Yield:
|
$3.3B
29.7
0.3%
|
|
|
|
|
Share this Index on Facebook
Share this Index on Twitter
|
|
| |
|
|
|
|
|
|
|
|
|
|
| |
|
| |

 |
Click
a column to sort | Scroll over columns for more information |
|
|
| ABMD |
$23.19 |
-0.36 |
-1.5% |
824,508 |
166% |
$875.3M |
- |
132% |
-2% |
2 Alerts (0 News) - View
|
|
|
| ALXN |
$80.41 |
+3.72 |
+4.8% |
2,365,202 |
198% |
$14.5B |
- |
91% |
-1% |
4 Alerts (0 News) - View
|
|
|
| AMLN |
$17.05 |
+0.58 |
+3.5% |
5,449,196 |
120% |
$2.4B |
- |
112% |
-7% |
1 Alert (0 News) - View
|
|
|
| ANGO |
$12.75 |
-0.31 |
-2.4% |
188,896 |
96% |
$333.5M |
- |
6% |
-26% |
No Alerts/News
|
|
|
| ATRI |
$257.94 |
-3.65 |
-1.4% |
2,872 |
154% |
$522.5M |
0.7% |
57% |
-2% |
No Alerts/News
|
|
|
| BCR |
$92.31 |
-0.44 |
-0.5% |
651,664 |
104% |
$7.9B |
0.8% |
14% |
-19% |
No Alerts/News
|
|
|
| CRME |
$2.55 |
-0.07 |
-2.7% |
78,354 |
33% |
$154.0M |
- |
37% |
-59% |
No Alerts/News
|
|
|
| CRY |
$5.75 |
-0.13 |
-2.2% |
42,676 |
60% |
$164.8M |
- |
44% |
-7% |
No Alerts/News
|
|
|
| ELGX |
$12.75 |
-0.01 |
-0.1% |
89,333 |
27% |
$733.5M |
- |
133% |
-7% |
1 Alert (1 News) - View
|
|
|
| EW |
$73.31 |
-0.69 |
-0.9% |
974,681 |
79% |
$8.4B |
- |
19% |
-20% |
No Alerts/News
|
|
|
| HGSI |
$10.00 |
+0.12 |
+1.2% |
6,769,567 |
82% |
$2.0B |
- |
54% |
-67% |
No Alerts/News
|
|
|
| HSP |
$34.11 |
-0.64 |
-1.8% |
2,281,653 |
124% |
$5.8B |
- |
27% |
-42% |
No Alerts/News
|
|
|
| KIPS |
$1.55 |
+0.09 |
+6.2% |
3,170 |
84% |
$22.9M |
- |
55% |
-81% |
No Alerts/News
|
|
|
| KNSY |
$23.75 |
-0.32 |
-1.3% |
31,031 |
92% |
$209.5M |
4.2% |
31% |
-19% |
No Alerts/News
|
|
|
| MDCO |
$20.99 |
-0.53 |
-2.5% |
947,714 |
143% |
$1.1B |
- |
70% |
-7% |
No Alerts/News
|
|
|
| MMSI |
$13.58 |
-0.10 |
-0.7% |
122,742 |
44% |
$574.2M |
- |
11% |
-32% |
No Alerts/News
|
|
|
| MNTA |
$15.61 |
-0.55 |
-3.4% |
2,076,421 |
168% |
$825.4M |
- |
54% |
-26% |
1 Alert (1 News) - View
|
|
|
| MYL |
$22.96 |
+0.07 |
+0.3% |
4,631,351 |
88% |
$9.6B |
- |
48% |
-10% |
No Alerts/News
|
|
|
| NKBP |
$2.40 |
-0.30 |
-11.1% |
8,190 |
148% |
$51.0M |
- |
7% |
-59% |
No Alerts/News
|
|
|
| PRX |
$37.05 |
-0.15 |
-0.4% |
114,601 |
32% |
$1.3B |
- |
49% |
-5% |
No Alerts/News
|
|
|
| SPNC |
$8.47 |
+0.08 |
+0.9% |
58,878 |
58% |
$280.4M |
- |
106% |
-5% |
No Alerts/News
|
|
|
| STJ |
$42.93 |
-0.58 |
-1.3% |
3,623,730 |
103% |
$13.8B |
1.9% |
34% |
-21% |
No Alerts/News
|
|
|
| STXS |
$0.84 |
+0.01 |
+1.5% |
273,473 |
108% |
$44.8M |
- |
24% |
-80% |
No Alerts/News
|
|
|
| THOR |
$34.52 |
+3.71 |
+12.0% |
4,866,084 |
681% |
$1.8B |
- |
39% |
-9% |
4 Alerts (1 News) - View
|
|
|
| UTHR |
$49.41 |
-0.49 |
-1.0% |
981,851 |
111% |
$2.9B |
- |
35% |
-30% |
No Alerts/News
|
|
|
| VASC |
$10.85 |
-0.04 |
-0.4% |
99,753 |
205% |
$178.5M |
- |
10% |
-21% |
1 Alert (0 News) - View
|
|
|
| VICL |
$3.50 |
-0.18 |
-4.9% |
1,050,489 |
70% |
$272.3M |
- |
106% |
-34% |
1 Alert (0 News) - View
|
|
|
| VOLC |
$27.88 |
-0.15 |
-0.5% |
227,867 |
41% |
$1.4B |
- |
30% |
-18% |
No Alerts/News
|
|
|
| VRX |
$48.49 |
-1.08 |
-2.2% |
2,292,233 |
111% |
$15.2B |
- |
51% |
-15% |
No Alerts/News
|
|
|
| WPI |
$58.25 |
+0.35 |
+0.6% |
1,199,668 |
45% |
$7.3B |
- |
8% |
-21% |
1 Alert (0 News) - View
|
|
|
|
Is this index incomplete or incorrect?
Got an idea for a new Index?
|
|
|
| |

|
| |
|
| |

|
| |
Momenta Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year End 2011 MNTA
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - February 09, 08:30AM from (www.globenewswire.com) CAMBRIDGE, Mass., Feb. 9, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing
Flag
Post a comment
Endologix Completes Enrollment in PEVAR Randomized Trial ELGX
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - February 09, 08:00AM from (www.globenewswire.com) IRVINE, Calif., Feb. 9, 2012 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments
Flag
Post a comment
Vical Reports 2011 Financial Results and Progress in Key Development Programs VICL
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - February 08, 06:30AM from (www.globenewswire.com) SAN DIEGO, Feb. 8, 2012 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today reported financial results for the year
Flag
Post a comment
AngioDynamics Launches DuraFlow(TM) 2 Chronic Hemodialysis Catheter ANGO
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - February 08, 06:30AM from (www.globenewswire.com) ALBANY, N.Y., Feb. 8, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive
Flag
Post a comment
Top Earnings Previews For Wednesday CSC S LVLT VICL CSCO WFM ENB IM RL MCO PAA AKAM TWX PRU ICE RAI V PNG GRPN NWSA
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - February 07, 01:30PM from (247wallst.com) We are entering into the last waves of the normalized quarterly earnings reports for companies with December 31 quarter-end
Flag
Post a comment
24/7 Wall St. Closing Bell BCO MRK QCOM DELL LEA EDMC BSX GMCR BZH AKS TTWO DO BIOS STLD BRCM EW NDAQ RGDX MNOV URG ZNGA VIAB
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - February 02, 04:08PM from (247wallst.com) All three major US stock indexes opened higher this morning, and spent the rest of the day bouncing around the neutral line.
Flag
Post a comment
Edwards Lifesciences Reports Solid Fourth Quarter Results EW
Linked by marketwire ( track newsfeed | ignore newsfeed ) - February 02, 04:01PM from (www2.marketwire.com) Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring,
Flag
Post a comment
Amylin Pharmaceuticals Continues to Soar in Wake of Bydureon Approval LLY ALKS AMLN GS JEF DB
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - February 02, 01:49PM from (www.benzinga.com) Last Friday, the FDA finally approved Bydureon, a once-weekly diabetes shot developed by Amylin Pharmaceuticals (NASDAQ:
Flag
Post a comment
Vical Announces News Release and Conference Call Schedule for 2011 Financial Results VICL
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - February 02, 06:30AM from (www.globenewswire.com) SAN DIEGO, Feb. 2, 2012 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will report
Flag
Post a comment
The Best Yielding Healthcare Dividend Stocks With Fastest Earnings Growth VIVO KNSY NDZ NVS GSK
Linked by Dividend ( track member | ignore member ) - February 02, 02:29AM from (long-term-investments.blogspot.com) Growth is a wonderful instrument for wealth building. I screened the healthcare sector by stocks with the highest earnings
Flag
Post a comment
Vascular Solutions Reports Fourth Quarter Results VASC
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - February 01, 04:10PM from (www.globenewswire.com)
MINNEAPOLIS, Feb. 1, 2012 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today reported financial results
Flag
Post a comment
Vascular Solutions Launches Reprocessing Service for ClosureFAST(R) Vein Catheters VASC
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - February 01, 04:05PM from (www.globenewswire.com) MINNEAPOLIS, Feb. 1, 2012 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it is marketing
Flag
Post a comment
Merit Medical Announces the Purchase of the Assets of Ostial Solutions, LLC MMSI
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - February 01, 09:30AM from (www.globenewswire.com) SOUTH JORDAN, Utah, Feb. 1, 2012 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and
Flag
Post a comment
|
|
|